New Study Shows Common Diabetes Drug Improves Symptoms in Genetic Form of ALS in Mice
University of Florida neuroscientists showed in a mouse-model study that metformin, a widely prescribed drug approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, reduces levels of specific mutant proteins central to the most common genetic form of ALS and frontotemporal dementia, or FTD, two intractable neurodegenerative diseases. The study, published […]